ALERTS FOR EXPECTED HALEON IPO
GSK spinning off its healthcare brands - register for updates
Haleon shares will start trading on the London Stock Exchange via an initial public offering (IPO) in the future.
GlaxoSmithKline is planning to spin off its consumer healthcare business in what could be one of the largest London Stock Exchange listings in a decade.
Haleon will own well-known household brands including Sensodyne toothpaste, Centrum vitamins, plus pain relief products Panadol and Advil. GlaxoSmithKline shareholders will automatically receive shares in the company but others could invest after it launches.
The listing of Haleon is subject to a shareholder vote on the 6 July. So there’s still a chance the listing won’t happen. Sign up for our alerts to stay up to date with the latest news, including:
- When the Haleon IPO will take place
- When and how you can buy Haleon shares
You’ll also get helpful tips and information on what to think about when investing in IPOs, plus news on selected other interesting IPOs.
Our IPO alerts service is for people who understand the risks of investing in equities, it is not personal advice. You should only consider investing if you’re free from significant debt (other than a mortgage) and have sufficient savings in an easily accessible account to cover for emergencies.
Investing in IPOs and individual companies isn’t right for everyone. It’s a higher-risk way to invest your money. When a company first lists on the stock market its share price can rise and fall quickly. The value of your investment depends on the fate of that company. If it fails, you risk losing your whole investment. Investors should make sure they understand the companies they’re investing in, the company specific risks, and make sure any businesses they own are held as part of a diversified portfolio. All investments and any income they produce will rise and fall in value, so you could make a loss. If you’re not sure of an investment's suitability for your circumstances, please speak to a financial adviser.